Since there are 618 rare missense variants in these genes in 143 cases, even a moderate enrichment suggests a large number of rare variants in SOX17-regulated genes may contribute to PAH-CHD risk. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.